Kiyomi Mashima

Analysis of the cost-effectiveness of treatment strategies for CML with incorporation of treatment discontinuation

Chihiro Yamamoto, Hirotomo Nakashima, Takashi Ikeda et al. · Blood Advances · 2019 · 38 citations · Full text

Pharmacy, Pharmacoeconomics, Pharmacotherapy +9

Comparison of gabexate mesilate and nafamostat mesilate for disseminated intravascular coagulation associated with hematological malignancies

Daisuke Minakata, Shin‐ichiro Fujiwara, Takashi Ikeda et al. · International Journal of Hematology · 2018 · 37 citations

Medicine, Hematology, Pharmacology +12

Comprehensive Analysis of the Activation and Proliferation Kinetics and Effector Functions of Human Lymphocytes, and Antigen Presentation Capacity of Antigen-Presenting Cells in Xenogeneic Graft-Versus-Host Disease

Yasufumi Kawasaki, Kazuya Sato, Hiroko Hayakawa et al. · Biology of Blood and Marrow Transplantation · 2018 · 31 citations · Full text

Life Sciences, Immunology, Pathobiology +11

Retrospective evaluation of the MEAM regimen as a conditioning regimen before autologous peripheral blood stem cell transplantation for lymphoma in two centers with different dosing schedules of melphalan

Miyuki Sugimoto, Shoko Ito, Kiyomi Mashima et al. · Annals of Hematology · 2016 · 26 citations

Medicine, Oncology, Chemotherapy +10

Evaluation of thrombotic events in patients with immune thrombocytopenia

Shoko Ito, Shin‐ichiro Fujiwara, Takashi Ikeda et al. · Annals of Hematology · 2019 · 23 citations

Medicine, Hematology, Immunology +14